Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefTags

From GxPlex

Revision as of 14:18, 16 July 2026 by Gxplex admin (talk | contribs) (Declare RefTags as Text property)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Text

Raw TAG-ID list for this reference (used for glossary queries).

previous 202050100250500next 20
Showing 20 pages using this property.
D
DEU SGB V - Sozialgesetzbuch FĂźnftes Buch 20-Dez-1988 § 35a +
TAG-00001-Med-rzn ++ TAG-00177-Ben-koB ++ TAG-00309-Rea-eal ++ TAG-00276-Mar-inh  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - pharmaceutical product +
TAG-00001-Med-rzn ++ TAG-00244-Def-ini  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 2 Absatz 1 – 2 +
TAG-00001-Med-rzn ++ TAG-00244-Def-ini ++ TAG-00316-Del-sbe  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 68 +
TAG-00002-Rad-esA ++ TAG-00011-Inv-tud ++ TAG-00014-Aux-kat ++ TAG-00098-IMP-tik  +
D
DEU StrlSchG - Strahlenschutzgesetz 03-Jan-2022 § 32 +
TAG-00002-Rad-esA ++ TAG-00340-Req-nfo ++ TAG-00057-Com-deR ++ TAG-00317-Obj-set  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - adverse reaction +
TAG-00003-Adv-cht ++ TAG-00244-Def-ini ++ TAG-00001-Med-rzn  +
G
GBR Directive 2001/20/EC 04-Apr-2001 Article 2 (n) +
TAG-00003-Adv-cht ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud  +
I
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Adverse Drug Reaction (ADR) +
TAG-00003-Adv-cht ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud ++ TAG-00066-Cau-enh  +
U
USA 21 CFR Part 312 09-Apr-2025 § 312.32 - Suspected adverse reaction +
TAG-00003-Adv-cht ++ TAG-00244-Def-ini ++ TAG-00066-Cau-enh ++ TAG-00320-Foo-eri ++ TAG-00011-Inv-tud  +
I
ICH ICH E8 Guideline R1 (2021) - +
TAG-00007-Cli-lin ++ TAG-00055-Stu-ngs  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 2 No. 1 +
TAG-00007-Cli-lin ++ TAG-00244-Def-ini ++ TAG-00001-Med-rzn ++ TAG-00003-Adv-cht  +
W
WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Clinical Research +
TAG-00007-Cli-lin ++ TAG-00317-Obj-set  +
WHO WHO - Guidance for best practices for clinical trials 2024 1.4 +
TAG-00008-Cli-ngK ++ TAG-00055-Stu-ngs ++ TAG-00145-Ran-ute ++ TAG-00338-Met-odi  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40 +
TAG-00008-Cli-ngK ++ TAG-00059-Reg-lat ++ TAG-00057-Com-deR ++ TAG-00001-Med-rzn  +
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12 +
TAG-00008-Cli-ngK ++ TAG-00134-Eth-kom ++ TAG-00041-Ame-run ++ TAG-00059-Reg-lat  +
E
EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 4 +
TAG-00008-Cli-ngK ++ TAG-00134-Eth-kom ++ TAG-00059-Reg-lat ++ TAG-00051-Eth-ngs  +
D
DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 4 Absatz 23 +
TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00010-Non-Stu  +
I
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Clinical Trial +
TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial +
TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00011-Inv-tud  +
U
USA 45 CFR Part 46 09-Apr-2025 § 46.102 (b) +
TAG-00008-Cli-ngK ++ TAG-00244-Def-ini ++ TAG-00277-Pla-par  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefTags&oldid=20452"